{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Script to\n",
    "1. get dosage range overlap across datasets, dosage range in GDSC andother metdata for each drug for analysis"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "NOTE!!!!!!: rerun script after generating \"GDSC_pair_dosage_range.csv\" from Task0a script"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "__author__ = 'Aanchal'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import FUNCTIONS as f\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "impClsOnly=1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "plotting_df=pd.DataFrame();"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### fetch dosage overlap"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "dr_metadata= f.get_common_drugs_metadata(\"../data/metadata_2019_08_15_aanchal.xlsx\", \"common_drugs\")\n",
    "\n",
    "plotting_df['Standard drug name']=dr_metadata['Standard drug name']\n",
    "plotting_df['dosage range overlap']=dr_metadata['dosage range overlap']\n",
    "plotting_df['GDSC dosage length']=dr_metadata['GDSC dosage length']\n",
    "plotting_df['GDSC min dosage']=dr_metadata['GDSC min dosage']\n",
    "plotting_df['GDSC max dosage']=dr_metadata['GDSC max dosage']"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## INITIALIZATION "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix=pd.read_csv('../data_processed/FittedCurvesCommonPairs_features/Feature_Matrix_FLatPerDrugFitting_15features.csv') # #Normalized_outliersCapped\n",
    "\n",
    "FeatureMatrix=FeatureMatrix[['Standard cell line name','Standard drug name','IS','mae_fitness','ic50_mode','m_mode','log2(max_dosage_bothDatasets)']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "pair_dosages=pd.read_csv('../data_processed/GDSC1_pair_dosage_range.csv').sort_values('cell line name')\n",
    "pair_dosages=pair_dosages.rename(columns={'cell line name':'Standard cell line name','drug name':'Standard drug name'})\n",
    "FeatureMatrix=pd.merge(FeatureMatrix, pair_dosages,on=['Standard cell line name','Standard drug name']) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "mu, sigma, Amp for 2 modes=> [ -4.02974493   1.10291438  76.75906788   4.5280398    5.10408333\n",
      " 174.8162648 ]\n",
      "Th=mu+std of 1st gaussian pofile: -1.9948772513860416\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from pylab import hist\n",
    "'''hist(FeatureMatrix['ic50_mode'] , bins=100) #FeatureMatrix['IS'] #FeatureMatrix['m_mode']\n",
    "plt.title('Distribution of ic50_mode for all pairs')\n",
    "plt.xlabel('value of ic50_mode')\n",
    "plt.ylabel('# pairs')\n",
    "plt.show()'''\n",
    "#temp=df[df['sensitivity_calls_ic50_label']==1]\n",
    "#hist(temp['ic50_mode'] , bins=100)\n",
    "\n",
    "[mus,stds, params,xh,yh] = f.fit_mixtureOfGaussians(FeatureMatrix[['ic50_mode']],[2.5,5,130,  10,5,60])\n",
    "\n",
    "#st_ind=np.where(params==max(mus))\n",
    "th=mus[0]+2*stds[0] #not using anymore since both the dsitributions mus tbe used to separate the 2 modes..not just 1\n",
    "\n",
    "th= f.split_bimodal(xh, f.bimodal(xh,params[0],params[1],params[2],params[3],params[4],params[5])  ,mus)[0]\n",
    "\n",
    "plt.axvline(x=mus[0], color='g', linestyle='--', label='mu1')\n",
    "plt.axvline(x=mus[1], color='g', linestyle='--', label='mu2')\n",
    "plt.axvline(x=th ,color='k', linestyle='--', label='threshold')\n",
    "#plt.axvline(x=7.06 ,color='r', linestyle='--', label='threshold')\n",
    "\n",
    "plt.xlabel('IC50_mode')\n",
    "plt.ylabel('# Pairs')\n",
    "plt.title('chosen threshold to separate resistant pairs='+str( th.round(2)) )\n",
    "print(\"Th=mu+std of 1st gaussian pofile:\", th)\n",
    "plt.savefig('../figures/InconsistencyFactorAnalysis/IC50_mode_distibution.svg')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "#code to check what each peak corresponds to\n",
    "\n",
    "t1=FeatureMatrix[FeatureMatrix['ic50_mode']<0][['Standard cell line name','Standard drug name']]\n",
    "t2=FeatureMatrix[(FeatureMatrix['ic50_mode']>=0) & (FeatureMatrix['ic50_mode']<7.06)][['Standard cell line name','Standard drug name']]\n",
    "t3=FeatureMatrix[FeatureMatrix['ic50_mode']>=7.06][['Standard cell line name','Standard drug name']]\n",
    "\n",
    "src=\"D:/AanchalMongia_phdClg/Phd/INTERNSHIP/Aanchal_GIS_PC/figures/FittedCurves_commonPairs_plots/\"\n",
    "dst=\"D:/AanchalMongia_phdClg/Phd/INTERNSHIP/Debugging_folder/commonPairs_3peaksOfIC50/\"\n",
    "f.copyPastePlots(src,dst+\"peak1/\",[],[],[],[],t1,0)\n",
    "f.copyPastePlots(src,dst+\"peak2/\",[],[],[],[],t2,0)\n",
    "f.copyPastePlots(src,dst+\"peak3/\",[],[],[],[],t3,0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "curves saved\n",
      "curves saved\n",
      "curves saved\n"
     ]
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "FeatureMatrix['Sensitivity_basedOnIC50th'] = np.where(FeatureMatrix['ic50_mode']> th, 1, 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7.063382706349541"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "th"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#filter Cls which havent been tested for all drugs\n",
    "if(impClsOnly==1):\n",
    "    all_cls=FeatureMatrix.groupby(FeatureMatrix['Standard cell line name']).count()[['Standard drug name']]\n",
    "    FeatureMatrix_impcls=FeatureMatrix.loc[FeatureMatrix['Standard cell line name'].isin(all_cls[all_cls['Standard drug name']==15].index)]\n",
    "else:\n",
    "    FeatureMatrix_impcls=FeatureMatrix\n",
    "\n",
    "#filter resistant Cls\n",
    "FeatureMatrix_sensitivePairs=FeatureMatrix_impcls[FeatureMatrix_impcls['ic50_mode']<=th]\n",
    "\n",
    "#get mean IS\n",
    "drug_wise_mean=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS'].mean() #takes med of all cols\n",
    "drug_wise_mean.rename(columns={'IS': 'mean IS'}, inplace=True)\n",
    "\n",
    "\n",
    "#get median IS\n",
    "drug_wise_median=FeatureMatrix_sensitivePairs.groupby('Standard drug name')['Standard drug name','IS','ic50_mode'].median() #takes med of all cols\n",
    "drug_wise_median.rename(columns={'IS': 'median IS', 'ic50_mode': 'median ic50_mode'}, inplace=True)\n",
    "\n",
    "AAA_matrix=FeatureMatrix_sensitivePairs\n",
    "AAA_matrix=AAA_matrix.set_index('Standard drug name')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "675"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(FeatureMatrix_sensitivePairs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "#df=FeatureMatrix_sensitivePairs.groupby(FeatureMatrix_sensitivePairs['Standard drug name']).agg({'Sensitivity_basedOnIC50nMaxDosage': [sum, \"count\"]})#['Standard drug name','Sensitivity'].describe()#.count()#.size()#.unstack()\n",
    "#df['fraction_resistant_CLs']=df['Sensitivity_basedOnIC50nMaxDosage']['sum']/df['Sensitivity_basedOnIC50nMaxDosage']['count']#['Sensitivity'][['sum']]#df['%age resistant CLs']=df['Standard drug name']\n",
    "#Sensitivity_basedOnIC50th shud be used to find fraction of resistant cls\n",
    "\n",
    "plotting_df['mean IS']=drug_wise_mean['mean IS']\n",
    "plotting_df['median IS']=drug_wise_median['median IS']\n",
    "plotting_df['median ic50_mode']=drug_wise_median['median ic50_mode']\n",
    "plotting_df['#total CLs']=FeatureMatrix.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#CLs tested for all']=FeatureMatrix_impcls.groupby('Standard drug name').count()['Standard cell line name']\n",
    "plotting_df['#sensitive CLs']=FeatureMatrix_sensitivePairs.groupby('Standard drug name').count()['Standard cell line name']\n",
    "\n",
    "plotting_df['Target Pathway']=dr_metadata['Target Pathway']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "###plotting_df=AAA_matrix.merge(plotting_df,left_index=True, right_index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "if(impClsOnly==1):\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs_testedFor15drugs.csv')\n",
    "else:\n",
    "    plotting_df.to_csv('../data_processed/InconsistencyFactorAnalysis/drug_analysis_onlySensitiveCLs.csv') "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Standard drug name</th>\n",
       "      <th>dosage range overlap</th>\n",
       "      <th>GDSC dosage length</th>\n",
       "      <th>GDSC min dosage</th>\n",
       "      <th>GDSC max dosage</th>\n",
       "      <th>mean IS</th>\n",
       "      <th>median IS</th>\n",
       "      <th>median ic50_mode</th>\n",
       "      <th>#total CLs</th>\n",
       "      <th>#CLs tested for all</th>\n",
       "      <th>#sensitive CLs</th>\n",
       "      <th>Target Pathway</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>name</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Crizotinib</th>\n",
       "      <td>Crizotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.113579</td>\n",
       "      <td>0.104483</td>\n",
       "      <td>2.798528</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>57</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Erlotinib</th>\n",
       "      <td>Erlotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.104502</td>\n",
       "      <td>0.093517</td>\n",
       "      <td>3.684525</td>\n",
       "      <td>97</td>\n",
       "      <td>66</td>\n",
       "      <td>34</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Lapatinib</th>\n",
       "      <td>Lapatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.111668</td>\n",
       "      <td>0.102102</td>\n",
       "      <td>3.160882</td>\n",
       "      <td>104</td>\n",
       "      <td>66</td>\n",
       "      <td>44</td>\n",
       "      <td>EGFR signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NVP-TAE684</th>\n",
       "      <td>NVP-TAE684</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.158247</td>\n",
       "      <td>0.145354</td>\n",
       "      <td>1.236829</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>58</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nilotinib</th>\n",
       "      <td>Nilotinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.119039</td>\n",
       "      <td>0.111031</td>\n",
       "      <td>2.913680</td>\n",
       "      <td>253</td>\n",
       "      <td>66</td>\n",
       "      <td>47</td>\n",
       "      <td>ABL signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Nutlin-3a</th>\n",
       "      <td>Nutlin-3a</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-5.000000</td>\n",
       "      <td>3.000000</td>\n",
       "      <td>0.103574</td>\n",
       "      <td>0.096268</td>\n",
       "      <td>3.630165</td>\n",
       "      <td>330</td>\n",
       "      <td>66</td>\n",
       "      <td>27</td>\n",
       "      <td>p53 pathway</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PD0325901</th>\n",
       "      <td>PD0325901</td>\n",
       "      <td>6.643856</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-10.000000</td>\n",
       "      <td>-2.000000</td>\n",
       "      <td>0.169005</td>\n",
       "      <td>0.156612</td>\n",
       "      <td>1.715962</td>\n",
       "      <td>326</td>\n",
       "      <td>66</td>\n",
       "      <td>43</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PHA-665752</th>\n",
       "      <td>PHA-665752</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.099693</td>\n",
       "      <td>0.088355</td>\n",
       "      <td>3.426608</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>47</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>PLX-4720</th>\n",
       "      <td>PLX-4720</td>\n",
       "      <td>7.678072</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-4.678072</td>\n",
       "      <td>3.321928</td>\n",
       "      <td>0.094246</td>\n",
       "      <td>0.085146</td>\n",
       "      <td>5.391576</td>\n",
       "      <td>322</td>\n",
       "      <td>66</td>\n",
       "      <td>17</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Paclitaxel</th>\n",
       "      <td>Paclitaxel</td>\n",
       "      <td>5.356144</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-11.287712</td>\n",
       "      <td>-3.287712</td>\n",
       "      <td>0.219389</td>\n",
       "      <td>0.222481</td>\n",
       "      <td>-4.787388</td>\n",
       "      <td>107</td>\n",
       "      <td>66</td>\n",
       "      <td>66</td>\n",
       "      <td>Mitosis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Palbociclib</th>\n",
       "      <td>Palbociclib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.163515</td>\n",
       "      <td>0.161882</td>\n",
       "      <td>3.168589</td>\n",
       "      <td>271</td>\n",
       "      <td>66</td>\n",
       "      <td>49</td>\n",
       "      <td>Cell cycle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Saracatinib</th>\n",
       "      <td>Saracatinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.115429</td>\n",
       "      <td>0.113814</td>\n",
       "      <td>3.276709</td>\n",
       "      <td>111</td>\n",
       "      <td>66</td>\n",
       "      <td>43</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Selumetinib</th>\n",
       "      <td>Selumetinib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.162186</td>\n",
       "      <td>0.148147</td>\n",
       "      <td>3.407303</td>\n",
       "      <td>314</td>\n",
       "      <td>66</td>\n",
       "      <td>33</td>\n",
       "      <td>ERK MAPK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Sorafenib</th>\n",
       "      <td>Sorafenib</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-6.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>0.122516</td>\n",
       "      <td>0.126827</td>\n",
       "      <td>2.562305</td>\n",
       "      <td>107</td>\n",
       "      <td>66</td>\n",
       "      <td>44</td>\n",
       "      <td>RTK signaling</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Tanespimycin</th>\n",
       "      <td>Tanespimycin</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>8.0</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.209852</td>\n",
       "      <td>0.206563</td>\n",
       "      <td>0.063913</td>\n",
       "      <td>330</td>\n",
       "      <td>66</td>\n",
       "      <td>66</td>\n",
       "      <td>Protein stability and degradation</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "             Standard drug name  dosage range overlap  GDSC dosage length  \\\n",
       "name                                                                        \n",
       "Crizotinib           Crizotinib              8.000000                 8.0   \n",
       "Erlotinib             Erlotinib              8.000000                 8.0   \n",
       "Lapatinib             Lapatinib              8.000000                 8.0   \n",
       "NVP-TAE684           NVP-TAE684              8.000000                 8.0   \n",
       "Nilotinib             Nilotinib              8.000000                 8.0   \n",
       "Nutlin-3a             Nutlin-3a              8.000000                 8.0   \n",
       "PD0325901             PD0325901              6.643856                 8.0   \n",
       "PHA-665752           PHA-665752              8.000000                 8.0   \n",
       "PLX-4720               PLX-4720              7.678072                 8.0   \n",
       "Paclitaxel           Paclitaxel              5.356144                 8.0   \n",
       "Palbociclib         Palbociclib              8.000000                 8.0   \n",
       "Saracatinib         Saracatinib              8.000000                 8.0   \n",
       "Selumetinib         Selumetinib              8.000000                 8.0   \n",
       "Sorafenib             Sorafenib              8.000000                 8.0   \n",
       "Tanespimycin       Tanespimycin              8.000000                 8.0   \n",
       "\n",
       "              GDSC min dosage  GDSC max dosage   mean IS  median IS  \\\n",
       "name                                                                  \n",
       "Crizotinib          -7.000000         1.000000  0.113579   0.104483   \n",
       "Erlotinib           -7.000000         1.000000  0.104502   0.093517   \n",
       "Lapatinib           -7.000000         1.000000  0.111668   0.102102   \n",
       "NVP-TAE684          -7.000000         1.000000  0.158247   0.145354   \n",
       "Nilotinib           -7.000000         1.000000  0.119039   0.111031   \n",
       "Nutlin-3a           -5.000000         3.000000  0.103574   0.096268   \n",
       "PD0325901          -10.000000        -2.000000  0.169005   0.156612   \n",
       "PHA-665752          -7.000000         1.000000  0.099693   0.088355   \n",
       "PLX-4720            -4.678072         3.321928  0.094246   0.085146   \n",
       "Paclitaxel         -11.287712        -3.287712  0.219389   0.222481   \n",
       "Palbociclib         -6.000000         2.000000  0.163515   0.161882   \n",
       "Saracatinib         -7.000000         1.000000  0.115429   0.113814   \n",
       "Selumetinib         -6.000000         2.000000  0.162186   0.148147   \n",
       "Sorafenib           -6.000000         2.000000  0.122516   0.126827   \n",
       "Tanespimycin        -8.000000         0.000000  0.209852   0.206563   \n",
       "\n",
       "              median ic50_mode  #total CLs  #CLs tested for all  \\\n",
       "name                                                              \n",
       "Crizotinib            2.798528         111                   66   \n",
       "Erlotinib             3.684525          97                   66   \n",
       "Lapatinib             3.160882         104                   66   \n",
       "NVP-TAE684            1.236829         111                   66   \n",
       "Nilotinib             2.913680         253                   66   \n",
       "Nutlin-3a             3.630165         330                   66   \n",
       "PD0325901             1.715962         326                   66   \n",
       "PHA-665752            3.426608         111                   66   \n",
       "PLX-4720              5.391576         322                   66   \n",
       "Paclitaxel           -4.787388         107                   66   \n",
       "Palbociclib           3.168589         271                   66   \n",
       "Saracatinib           3.276709         111                   66   \n",
       "Selumetinib           3.407303         314                   66   \n",
       "Sorafenib             2.562305         107                   66   \n",
       "Tanespimycin          0.063913         330                   66   \n",
       "\n",
       "              #sensitive CLs                     Target Pathway  \n",
       "name                                                             \n",
       "Crizotinib                57                      RTK signaling  \n",
       "Erlotinib                 34                     EGFR signaling  \n",
       "Lapatinib                 44                     EGFR signaling  \n",
       "NVP-TAE684                58                      RTK signaling  \n",
       "Nilotinib                 47                      ABL signaling  \n",
       "Nutlin-3a                 27                        p53 pathway  \n",
       "PD0325901                 43                 ERK MAPK signaling  \n",
       "PHA-665752                47                      RTK signaling  \n",
       "PLX-4720                  17                 ERK MAPK signaling  \n",
       "Paclitaxel                66                            Mitosis  \n",
       "Palbociclib               49                         Cell cycle  \n",
       "Saracatinib               43                      RTK signaling  \n",
       "Selumetinib               33                 ERK MAPK signaling  \n",
       "Sorafenib                 44                      RTK signaling  \n",
       "Tanespimycin              66  Protein stability and degradation  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "plotting_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
